Outlook Therapeutics
OTLK
OTLK
70 hedge funds and large institutions have $32.6M invested in Outlook Therapeutics in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 7 closing their positions.
Holders
70
Holders Change
+7
Holders Change %
+11.11%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
21
Reduced
21
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$8.12M |
| 2 |
2
Renaissance Technologies
New York
|
$1.58M |
| 3 |
3
Two Sigma Advisers
New York
|
$1.21M |
| 4 |
4
Two Sigma Investments
New York
|
$1.05M |
| 5 |
GCP
5
GSA Capital Partners
London,
United Kingdom
|
$286K |
